Acta neurologica Scandinavica
-
To alert clinicians to the stroke risk associated with carotid artery injury secondary to attempted internal jugular venous (IJV) cannulation. ⋯ Cannulation of the IJV using visible and palpable landmarks is associated with a risk of stroke. Arterial injury and stroke should be mentioned when consent is obtained for cannulation. Consideration should be given to a reduction of the arterial injury risk by using ultrasound guidance during line insertion.
-
Acta Neurol. Scand. · Mar 2002
Focal enhancement of motor cortex excitability during motor imagery: a transcranial magnetic stimulation study.
In order to learn more about the physiology of the motor cortex during motor imagery, we evaluated the changes in excitability of two different hand muscle representations in the primary motor cortex (M1) of both hemispheres during two imagery conditions. ⋯ Imagery of unilateral simple movements is associated with increased excitability only of a highly specific representation in the contralateral M1 and does not differ between hemispheres.
-
Acta Neurol. Scand. · Mar 2002
Clinical TrialChanges of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis.
The Multiple Sclerosis Functional Composite (MSFC) comprises quantitative functional measures of leg, hand/arm and cognitive function. We examined the responsiveness of the MSFC compared with the Expanded Disability Status Scale (EDSS) during treatment of relapses in patients with multiple sclerosis (MS). ⋯ During and after treatment of relapses in patients with MS, the MSFC appears to be more sensitive in detecting changes in function than the EDSS.
-
Acta Neurol. Scand. · Mar 2002
Randomized Controlled Trial Clinical TrialA transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis.
To investigate the efficacy of two different high doses of intravenous methylprednisolone (IVMP) during Multiple Sclerosis (MS) relapses. ⋯ The dose of 2 g/day of IVMP is more effective in MS relapse.